Physician
Murdock Pediatric Services PLLC
Murdock Pediatric Services PLLC was paid $806K by Medicaid between Jan 2020 and Dec 2024, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoMURDOCK PEDIATRIC SERVICES PLLC
CLEVELAND, TX 77327
CLEVELAND, TX 77327
33aNPI1831416353assigned 04/23/2010
33bProvider typePediatrics Physician
28Total paid$806K
24GClaims43,250
24DCodes billed49
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#417 of 1,136
Median peer was paid$329K
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,477 | $39K | |
| 2021 | 11,744 | $202K | |
| 2022 | 12,584 | $232K | |
| 2023 | 9,285 | $192K | |
| 2024incomplete | 7,160 | $142K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 5,940 | 5,050 | $210K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11% | 1,104 | 1,031 | $85K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.0% | 1,597 | 1,360 | $73K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.7% | 960 | 907 | $70K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.6% | 813 | 760 | $69K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.8% | 5,532 | 2,414 | $55K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.6% | 2,343 | 2,043 | $53K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.3% | 722 | 652 | $51K |
| 87428 | 4.1% | 791 | 714 | $33K | |
| S8301 | Infection control supplies, not otherwise specified | 2.6% | 7,492 | 6,263 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 1,161 | 1,096 | $16K |
| 92567 | 1.7% | 1,148 | 1,022 | $13K |
37 more codes
| 97802 | 1.6% | 2,584 | $13K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 875 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 488 | $6K |
| 90461 | <1% | 1,427 | $6K | |
| 87430 | <1% | 495 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 389 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 112 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 222 | $2K |
| 90671 | <1% | 213 | $2K | |
| 96160 | <1% | 846 | $2K | |
| 81003 | <1% | 732 | $1K | |
| 97169 | <1% | 46 | $1K | |
| 90661 | <1% | 72 | $1K | |
| 92551 | <1% | 176 | $327.01 | |
| 90651 | <1% | 42 | $269.14 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 19 | $233.81 |
| 87807 | <1% | 17 | $111.10 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 366 | $45.04 |
| 90686 | <1% | 566 | $40.60 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $26.83 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 136 | $0.41 |
| 90619 | <1% | 97 | $0.27 | |
| 90697 | <1% | 115 | $0.13 | |
| 99401 | 0% | 1,930 | $0.00 | |
| 90670 | 0% | 490 | $0.00 | |
| 99173 | 0% | 265 | $0.00 | |
| 90707 | 0% | 66 | $0.00 | |
| 90648 | 0% | 42 | $0.00 | |
| 90633 | 0% | 168 | $0.00 | |
| 99072 | 0% | 123 | $0.00 | |
| 90734 | 0% | 24 | $0.00 | |
| 90715 | 0% | 17 | $0.00 | |
| 90710 | 0% | 91 | $0.00 | |
| 90680 | 0% | 257 | $0.00 | |
| 90716 | 0% | 64 | $0.00 | |
| 90723 | 0% | 16 | $0.00 | |
| 90696 | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, TRINA (OWNER)